Siehe Firmendetails

Origimm (‘Origins of Immunity’) is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets for the prevention and treatment of infectious diseases and dermatological conditions associated with various microbial species. Origimm develops a unique preventive and therapeutic solution for two indications, acne vulgaris and implant-associated infections targeting Propionibacterium acnes.